Literature DB >> 21937688

The genetic basis of the endocannabinoid system and drug addiction in humans.

Jose Antonio López-Moreno1, Victor Echeverry-Alzate, Kora-Mareen Bühler.   

Abstract

The cannabinoid receptor (CNR1) and the fatty acid amide hydrolase (FAAH) genes are located on chromosomes 6 and 1 in the 6q15 and 1p33 cytogenetic bands, respectively. CNR1 encodes a seven-transmembrane domain protein of 472 amino acids, whereas FAAH encodes one transmembrane domain of 579 amino acids. Several mutations found in these genes lead to altered mRNA stability and transcription rate or a reduction of the activity of the encoded protein. Increasing evidence shows that these functional mutations are related to dependence upon cocaine, alcohol, marijuana, heroin, nicotine and other drugs. One of the most compelling associations is with the C385A single nucleotide polymorphism (SNP), which is found in the FAAH gene. For all of the genetic polymorphisms reviewed here, it is difficult to form overall conclusions due to the high diversity of population samples being studied, ethnicity, the use of volunteers, heterogeneity of the recruitment criteria and the drug addiction phenotype studied. Care should be taken when generalizing the results from different studies. However, many works have repeatedly associated polymorphisms in the CNR1 and FAAH genes with drug-related behaviours; this suggests that these genes should be examined in further genetic studies focusing on drug addiction and other psychiatric disorders.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21937688     DOI: 10.1177/0269881111416689

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  29 in total

Review 1.  Endocannabinoid signalling in reward and addiction.

Authors:  Loren H Parsons; Yasmin L Hurd
Journal:  Nat Rev Neurosci       Date:  2015-09-16       Impact factor: 34.870

2.  Impulsivity, variation in the cannabinoid receptor (CNR1) and fatty acid amide hydrolase (FAAH) genes, and marijuana-related problems.

Authors:  L Cinnamon Bidwell; Jane Metrik; John McGeary; Rohan H C Palmer; S Francazio; Valerie S Knopik
Journal:  J Stud Alcohol Drugs       Date:  2013-11       Impact factor: 2.582

Review 3.  Cannabis and the Developing Brain: Insights into Its Long-Lasting Effects.

Authors:  Yasmin L Hurd; Olivier J Manzoni; Mikhail V Pletnikov; Francis S Lee; Sagnik Bhattacharyya; Miriam Melis
Journal:  J Neurosci       Date:  2019-10-16       Impact factor: 6.167

4.  Risky alcohol consumption in young people is associated with the fatty acid amide hydrolase gene polymorphism C385A and affective rating of drug pictures.

Authors:  Kora-Mareen Bühler; Evelio Huertas; Víctor Echeverry-Alzate; Elena Giné; Eduardo Moltó; Lluis Montoliu; Jose Antonio López-Moreno
Journal:  Mol Genet Genomics       Date:  2014-01-10       Impact factor: 3.291

5.  Fatty acid amide hydrolase (FAAH) inactivation confers enhanced sensitivity to nicotine-induced dopamine release in the mouse nucleus accumbens.

Authors:  Francisco J Pavon; Antonia Serrano; Nimish Sidhpura; Ilham Polis; David Stouffer; Fernando Rodriguez de Fonseca; Benjamin F Cravatt; Rémi Martin-Fardon; Loren H Parsons
Journal:  Addict Biol       Date:  2017-06-29       Impact factor: 4.280

6.  The fatty acid amide hydrolase C385A variant affects brain binding of the positron emission tomography tracer [11C]CURB.

Authors:  Isabelle Boileau; Rachel F Tyndale; Belinda Williams; Esmaeil Mansouri; Duncan J Westwood; Bernard Le Foll; Pablo M Rusjan; Romina Mizrahi; Vincenzo De Luca; Qian Zhou; Alan A Wilson; Sylvain Houle; Stephen J Kish; Junchao Tong
Journal:  J Cereb Blood Flow Metab       Date:  2015-06-03       Impact factor: 6.200

7.  Fatty acid amide hydrolase-morphine interaction influences ventilatory response to hypercapnia and postoperative opioid outcomes in children.

Authors:  Vidya Chidambaran; Valentina Pilipenko; Kristie Spruance; Raja Venkatasubramanian; Jing Niu; Tsuyoshi Fukuda; Tomoyuki Mizuno; Kejian Zhang; Kenneth Kaufman; Alexander A Vinks; Lisa J Martin; Senthilkumar Sadhasivam
Journal:  Pharmacogenomics       Date:  2016-12-15       Impact factor: 2.533

8.  Opposing actions of CRF-R1 and CB1 receptors on VTA-GABAergic plasticity following chronic exposure to ethanol.

Authors:  Benjamin A Harlan; Howard C Becker; John J Woodward; Arthur C Riegel
Journal:  Neuropsychopharmacology       Date:  2018-06-09       Impact factor: 7.853

Review 9.  Weighing the Evidence: A Systematic Review on Long-Term Neurocognitive Effects of Cannabis Use in Abstinent Adolescents and Adults.

Authors:  Florian Ganzer; Sonja Bröning; Stefanie Kraft; Peter-Michael Sack; Rainer Thomasius
Journal:  Neuropsychol Rev       Date:  2016-04-28       Impact factor: 7.444

10.  Genetic risk signatures of opioid-induced respiratory depression following pediatric tonsillectomy.

Authors:  Jacek Biesiada; Vidya Chidambaran; Michael Wagner; Xue Zhang; Lisa J Martin; Jaroslaw Meller; Senthilkumar Sadhasivam
Journal:  Pharmacogenomics       Date:  2014-11       Impact factor: 2.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.